References:
  1. Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA Vaccines. Circulation 2021; 144(6): 471-484
  2. Gang LV, Yuan J, Xiong X, et al. Mortality rate and characteristics of deaths following COVID-19 vaccination. Front Med (Lausanne) 2021; 8670370
  3. Su JR, McNeil MM, Welsh KJ, et al. Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018.Vaccine 2021; 39:839–845.
  4. Barth C, Mahfoud F, Ukena C,et al. Update on myocarditis. J Am Coll Cardiol 2012;59: 779-792.
  5. Marshall M, Ferguson ID, Lewis P, et al. Symptomatic acute myocarditis in seven adolescents following Pfizer-BioNTech COVID-19 vaccination. Pediatrics 2021;2
  6. Graham BS. Rapid COVID-19 vaccine development.Science 2020; 368:945–946.
  7. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009;53(17): 1475–1487.
  8. Uziębło-Życzkowska B, Krzesiński P, et al. Cushing’s disease: subclinical left ventricular systolic and diastolic dysfunction revealed by speckle tracking echocardiography and tissue Doppler imaging. Front Endocrinol (Lausanne) 2017; 8:1–8.
  9. Erley J, Genovese D, Tapaskar N, et al. Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement. J Cardiovasc Magn Reson 2019; 21(1):46
  10. Uziębło-Życzkowska B, Mielniczuk M, Ryczek R, et al. Myocarditis successfully diagnosed and controlled with speckle tracking echocardiography. Cardiovasc Ultrasound 2020;18(1):19